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DEFECTIVE LYMPHOPOIESIS IN THE BONE MARROW OF
MOTHEATEN (me/me) AND VIABLE MOTHEATEN (me"/me")
MUTANT MICE
III. Normal Mouse Bone Marrow Cells Enable me"/me° Prothymocytes
to Generate Thymocytes after Intravenous Transfer
(5).
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Mice homozygous for the recessive single gene mutations motheaten (me/me)
and viable motheaten (me"/me") develop autoimmune and severe combined
immunodeficiency disorders (1). Previous results from our laboratory (2) dem-
onstrated the absence of detectable prothymocyte activity in the bone marrow
of me/me and me"/me" mice after intravenous injection into sublethally irradiated
recipients. However, when the intrathymic (i.t.) adoptive transfer assay for
prothymocytes (3) was used, me/me and me"/me" thymocytes were generated in
numbers equivalent to those produced by bone marrow cells from apparently
normal +/- littermates (2). These results suggested that me/me and me"/me"
prothymocytes are present in normal numbers, but that they are unable to home
effectively to the thymus via the blood.
In another study (4), we demonstrated that me"/me" bone marrow can generate
presumptive T-lineage terminal deoxynucleotidyl transferase-positive (TdT+)
cells in vitro when cultured on bone marrow stromal cell feeder layers from
normal mice; but that feeder layers from me/me and me"/me' mice fail to support
the generation of TdT+ bone marrow cells from normal animals. These results
suggested that at least some ofthe defective lymphopoiesis seen in these mutant
mice may be secondary to abnormalities in the bone marrow microenvironment
In the present study, the results of mixing experiments suggest that a popula-
tion ofradiosensitive bone marrow cells from normal mice can restore the ability
of me"/me" prothymocytes to generate thymocytes after intravenous injection.
The results provide further evidence that a microenvironmental defect may be
responsible for the developmental abnormalities of lymphoid precursor cells in
me"/me° mice, and suggest that the me"/me" mutant mouse may be a useful model
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FIGURE 1 .
￿
Generation of donor-origin (Ly-1 .2) thymocytes as a function of the dose of
C57BL/6 +/+ wild-type ("), C57BL/6J-me"/me" (/) or C57BL/6J +/- littermate (O) bone
marrow cells injected (A) intrathymically or (B) intravenously into irradiated (600 rad)
C57BL/6-Ly-1 .1 wild-type recipients l7 d previously. Each point represents the mean ofthree
animals. The best fit lines were determined by linear regression analysis: (A) me/me", r2 =
1.00, slope = 257.9; +/- littermate, r2 = 0.96, slope = 230.8; +/+ wild-type, r2 = 0.96, slope
= 222.6; (B) +/- littermate, r2 = 0.90, slope = 5.28; +/+ wild-type, r2 = 0.84, slope = 4.99.
with which to identify the cells and/or factors in bone marrow that help to
regulate the differentiation, proliferation, and/or migration of prothymocytes.
Animals.
￿
5-7-wk-old C57BL/6J-me"/me" mice (H-2b, Ly 1 .2) and their phenotypically
normal littermate controls (approximately 2 /3 +/me" and )/s +/+) were obtained from the
colony maintained by L. Shultz at The Jackson Laboratory, Bar Harbor, ME. Only me"lme"
mice have been used in the present study, since they have longer lifespans than do the
me/me mice (1). C57BL/6 wild-type (+/+) mice (H-26, Ly-1 .2) were obtained from the
Animal Genetics and Production Branch, National Cancer Institute, Frederick, MD.
Breeding pairs of congenic C57BL/6-Ly-1 .1 mice (wild-type, +/+) (H-2b, Ly-1 .1) were
obtained from Dr. Edward Boyse, Sloan-Kettering, New York.
Immunofluorescence.
￿
Thymocyte cell suspensions were labeled with mAbs to the mouse
Ly-1 .1 or Ly-1 .2 alloantigens (New England Nuclear, Boston, MA), to distinguish between
donor-and host-origin cells, and developed with a fluorescein-conjugated F(ab')2 fragment
ofa goat anti-mouse IgG (heavy and light chain specific) (Cappel Laboratories, Cochran-
ville, PA) (2). Labeled cells were analyzed on a FACS IV (Becton Dickinson & Co.,
Sunnyvale, CA).
Adoptive Transfer Assays for Prothymocytes.
￿
The intravenous and intrathymic quantita-
tive adoptive transfer assays for prothymocytes have been described previously (3). In
brief, irradiated recipients (600 rad) were injected with graded doses of bone marrow
cells intravenously into the tail vein or intrathymically into each thymic lobe. At day 17
after cell transfer, the recipients were sacrificed and the numbers of donor- and host-
origin thymocytes were determined by immunofluorescence on the FACS.
Results
Prothymocyte Activity ofBone Marrow Cellsfrom me°/me, +/- Littermate, and +/
+ Wild-type Mice. To confirm our previous observations (2) and to ensure that
+/- littermate mice can serve as normal controls despite the possible presence
of a recessive me" allele, we have compared the relative prothymocyte activities
of me"/me", +/- littermate, and +/+ wild-type C57BL/6-Ly-1 .2 bone marrow
cells after injection intrathymically and intravenously into irradiated (600 rad)
C57BL/6-Ly-1 .1 mice. Results of the intrathymic assay (Fig. 1 A) show that the1164
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TABLE I
Inability ofme'/me' Prothymocytes Recoveredfrom the Bone Marrow ofAn Intermediate +/+
Wild-type Recipient to Generate Thymocytes when Transferred Intravenously into a
Second Wild-type Recipient
Irradiated (600 tad) C57BL/6-Ly 1.1 wild-type (+/+) mice were injected i.v. with me"/me" (Ly-1.2)or +/- littermate
(Ly-1 .2) bone marrow cells. 17 d later, bone marrow cells from theseprimary recipients were transferred i.v. or i.t.
into irradiated (600 rad) C57BL/6-Ly-1 .1 and C57BL/6-Ly-1 .2 wild-type secondary recipients. Donor-origin (Ly-
1 .2) and host-origin (Ly-1.1) thymocytes were quantified by FACS analysis 17 d later. Results are the means t SD
of three animals per group.
number of donor-origin thymocytes generated at day 17 by all three sources of
bone marrow cells was directly proportional to the number of cells transferred
over the dose range of 0.075 X 106 to 0.2 X 106 cells. Moreover, no significant
differences were observed between the numbers of donor-origin thymocytes
generated by each group at any given cell dose.
Like the intrathymic assay, results ofthe intravenous assay (Fig. I B) show that
the number of donor-origin thymocytes generated at day 17 were directly
proportional to the number of +/- littermate or +/+ wild-type bone marrow
cells transferred over the dose range of 2.5 X 106 to 10 X 106 cells; and that
there were no significant differences in the numbers ofdonor-origin thymocytes
generatedby either groupatany given celldose. However, unlike theintrathymic
assay, as many as 10 X 106 me"/me° bone marrow cells failed to generate any
detectable donor-origin thymocytes in the intravenous assay system.
Passage of me/me' Bone Marrow Cells Through Irradiated +/+ Wild-type Recipi-
ents Does Not Restore Prothymocyte Activity in the Intravenous Assay. 106 me"/me"
(Ly-1.2) or +/- littermate (Ly-1 .2) bone marrow cells were transferred intrave-
nously into sublethally irradiated (600 rad) C57BL/6-Ly-1 .1 wild-type recipients.
17 d later the bone marrow ofthese recipient mice was harvested and tested for
prothymocyte activity by intravenous and intrathymic injection into sublethally
irradiated (600 rad) C57BL/6-Ly-1 .1 and C57BL/6-Ly-1 .2 secondary recipients.
No mev/mev-origin (Ly-1 .2) thymocytes were detected in the intravenous-injected
secondary recipients at day 17; whereas 76.9 X 106 mev/me"-origin thymocytes
were present in the intrathymic-injected secondary recipients (Table I). In
contrast, 58.4 X 106 and 74.5 X 106 donor-origin (Ly-1.2) thymocytes were
detected, respectively, in both intravenous-injected and intrathymic-injected
secondary recipients when +/- littermate bone marrow cells were passaged.
Fewer than 3 X 106 host-origin (Ly-1 .1) thymocytes were present after either
intravenousor intrathymic injection ofbone marrowcells from theprimary hosts
into Ly-1.2 secondary recipients.
Mixing ofme'/me and +/+ Wild-type Bone Marrow Cells Enables me"/me' prothy-
Origin oftrans-
Primary recipient of bone
marrow cell transfer
Secondary recipient of bone
marrow cell transfer
Number ofthymocytes
in secondary
per thymus
recipients(x 10-8)
ferred cells Number of Route cells Route Number ofcells Donor-origin Host-origin
+/- i.v. 10 x 108 i.v. 14.0 x 106 58.4 t 14.1 2.6 t 4.1
Littermate i.t. 2.5 x 106 74.5 t 25.5 2.2
me'/me' i.v. 10 x 106 i.v. 14.0 x 106 <1 2.4 t 3.3
i.t. 2.5 x 106 76.9 t 5.4 1.9 t 0.6KOMSCHLIES ET AL .
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FIGURE 2 .
￿
Generation of me"/me"-origin (Ly 1 .2p(0) and wild-type-origin (Ly-1 .1) (Ci) thy-
mocytes following the transfer of mixtures of me"/me and C57BL/6-Ly 1 .1 wild-type bone
marrow cells (A) intrathymically or (B) intravenously into irradiated (600 rad) C57BL/6-Ly-
1.1 or C57BL/6-Ly-1.2 wild-type recipients, respectively, 17 d previously . The C57BL/6-Ly-
1.1 wild-typebone marrow cells were mixed at a constant dose (0 .1 x 10 6 intrathymic or 2.5
X 106 intravenous) with varying doses of me"/rne" (Ly-1 .2) bone marrow cells. Each value
represents themean of three animals .
mocytes to Generate Thymocytes When Transferred Intravenously.
￿
Varying numbers
of me"/me" (Ly-1 .2) bone marrow cells were mixed with 0.1 X 106 or 2.5 X 106
wild-type (C57BL/6-Ly-1 .1) bone marrow cells and injected intrathymically or
intravenously, respectively, into irradiated (600 rad) C57BL/6-Ly-1 .1 and
C57BL/6-Ly-1 .2 recipients . As shown in Fig . 2, A and B, me"/me' thymocytes
were generated in a dose-related manner in B6-Ly-1 .1 recipients both after
intrathymic and intravenous injection . In addition, the number of wild-type
origin thymocytes that were generated in B6-Ly-1 .2 recipients by the mixture of
bone marrow cells was equivalent to that expected if only wild-type bone marrow
cells had been injected intrathymically or intravenously (compare Fig. 1, A and
B, with Fig. 2, A and B) .
Discussion
The results of the present study demonstrate that the inability of me"/me"
prothymocytes to repopulate the thymus of irradiated recipients after intrave-
nous injection can be corrected by the addition of wild-type bone marrow cells
before injection . Thesimplest explanation for this observation is that apopulation
of normal bone marrow cells (and/or their products), which enable me"/me"
prothymocytes to home to and/or differentiate within the thymus, are deficient
or defective in me"/me" mice. Although our previous in vitro experiments favor
a role for bone marrow macrophages in this process (4), it is also possible that
other cell types, including normal prothymocytes (or autocrine factors there-
from), may be involved (but see below) . However, it is unlikely that the inability
of me"/me" prothymocytes to home effectively to the thymus results from inhibi-
tory cells or factors, since the mixing ofme"/me"and wild-type bone marrow cells
before intravenous transfer does not decrease the generation of wild-type thy-
mocytes (Fig . 2) . Moreover, it is unlikely that a defect within the thymus itself is
involved, inasmuch as normal bone marrow cells, injected intravenously, readily
repopulate the thymus of irradiated me/me and me"/me" mice (1) .
Unfortunately, very few host-origin prothymocytes were detected, by either1166
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the intravenous or the intrathymic adoptive transfer assays, in wild-type recipients
of me"/me" bone marrow cells 17 d after irradiation (Table 1) . Thus we were not
able to determine whether wild-type prothymocytes can correct the develop-
mental defect of me°/me"-origin prothymocytes. However, it has been observed
in other studies (Shultz, L., unpublished observations) that bone marrow cells
from scid mice, which themselves lack detectable prothymocytes in the intrave-
nous transfer system (1), enable me"/me" prothymocytes to generate thymocytes
in the intravenous transfer system. This suggests that normal prothymocytes are
not implicated in this phenomenon.
Whatever its identity, the normal bone marrow cell(s)/factor(s) that restores
me"/me" prothymocyte activity after intravenous transfer appears to be relatively
radiosensitive. Not only did me"/me" bone marrow cells fail to generate thymo-
cytes after intravenous injection into 600 rad irradiated wild-type recipients, but
bone marrow cells obtained from theserecipients 17 d later also failed to generate
me"/me"-origin thymocytes upon secondary transfer intravenously. Yet these same
17-d postreconstitution bone marrow cells readily generated me"/me"-origin thy-
mocytes in the intrathymic assay system, thereby indicating that many me"/me"
prothymocytes were present. In more recent experiments we have demonstrated
that bone marrow obtained from wild-type mice 72 h after 600 rad whole-body
irradiation fails to restore me"/me" prothymocyte activity in the intravenous
transfer system (our unpublished observations). Thus, the putative accessory
function rapidly disappears from normal bone marrow after 600 rad and is not
replaced within 17 d.
The results of the intrathymic transfer experiments suggest that, once in the
thymic microenvironment, me"/me" prothymocytes no longer require other ra-
diosensitive bone marrow cells to proliferate and/or differentiate. If this is
correct, then the failure of me"/me" prothymocytes to generate thymocytes after
intravenous injection is most likely due to their inability to home to the thymus.
Alternatively, radiosensitive bone marrow cells may indeed be required to
support thymocytopoiesis after prothymocytes enter the thymus, but in me"/me"
mice these cells may themselves be defective in their thymus-homing abilities.
Under these circumstances, me'/me" prothymocytes could have normal thymus-
homing capacities and still not be detectable in the intravenous transfer system.
Experiments using combined intrathymic and intravenous transfer of wild-
type and me"/me" bone marrow cells, respectively, have been initiated to distin-
guish between these alternatives. However, the existence of a thymus-homing
defect of prothymocytes and/or other bone marrow cells in me"/me' mice is
further supported by the results of in vitro migration assays, in which only 0 .7%
of me"/me" bone marrow cells migrated in response to supernatants of normal
thymus, as compared with 8 .8% of +/- littermate bone marrow cells (6) . In
addition, the possible role of la' nonlymphoid bone marrow cells in prothymocyte
maturation and migration is being explored. Such Ia'' cells have been shown to
help regulate thymocytopoiesis in vivo (7) and in vitro (8), to be relatively
radiosensitive (9), and to migrate from bone marrow to thymus (9) .
Summary
Bone marrow prothymocytes from me/me and me"/me" mutant mice fail to
generate thymocytes in irradiated (600 rad) +/+ wild-type recipients afterKOMSCHLIES ET AL.
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intravenous injection. However, these same prothymocytes readily generate
thymocytes after intrathymic injection . The results of the present study demon-
strate that this apparent defect in the thymus-homing capacity of me"/me° prothy-
mocytes can be corrected by mixing irradiated wild-type bone marrow cells with
me"/me" bone marrow cells before intravenous injection. However, this defect is
not corrected by passage of me"/me" bone marrow cells through the bone marrow
of irradiated wild-type recipients. One interpretation of these results is that the
maturation of prothymocytes is reversibly arrested in me"/me" mice by a defect
in the radiosensitive compartment of the bone marrow microenvironment.
Receivedfor publication 13 May 1987 and in revisedform 22July 1987.
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